SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-001577
Filing Date
2023-01-04
Accepted
2023-01-04 17:01:07
Documents
17
Period of Report
2022-12-28
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d426805d8k.htm   iXBRL 8-K 42779
2 EX-10.1 d426805dex101.htm EX-10.1 120537
3 EX-10.2 d426805dex102.htm EX-10.2 8760
4 EX-10.3 d426805dex103.htm EX-10.3 9706
5 EX-99.1 d426805dex991.htm EX-99.1 188746
  Complete submission text file 0001193125-23-001577.txt   594243

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA pkbo-20221228.xsd EX-101.SCH 4080
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE pkbo-20221228_def.xml EX-101.DEF 14048
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE pkbo-20221228_lab.xml EX-101.LAB 23373
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE pkbo-20221228_pre.xml EX-101.PRE 15081
11 EXTRACTED XBRL INSTANCE DOCUMENT d426805d8k_htm.xml XML 5486
Mailing Address 3350 W BAYSHORE RD. SUITE 100 PALO ALTO CA 94303
Business Address 3350 W BAYSHORE RD. SUITE 100 PALO ALTO CA 94303 (650) 549-9103
Peak Bio, Inc. (Filer) CIK: 0001834645 (see all company filings)

IRS No.: 852448157 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39951 | Film No.: 23507594
SIC: 2836 Biological Products, (No Diagnostic Substances)